Diam »

Kiniksa Pharmaceuticals Intl P Ord Shs Cl A shares owned by Diam

Quarter-by-quarter ownership of Kiniksa Pharmaceuticals Intl P Ord Shs Cl A (KNSA) shares owned by Diam from 13F filings

Historical chart of Diam investment in Kiniksa Pharmaceuticals Intl P Ord Shs Cl A

Tip: Access up to 7 years of quarterly data

All positions including Kiniksa Pharmaceuticals Intl P Ord Shs Cl A held by Diam consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kiniksa Pharmaceuticals Intl P Ord Shs Cl A by Diam

Quarter filed Position value Share count Share price at filing
2025-09-30 $319k 8.2k 38.83
2025-06-30 $373k 14k 27.67
2025-03-31 $41k 1.9k 22.21

More positions owned by Diam

Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Europe Etf (VGK)
Ishares Core Msci Emkt (IEMG)
JPMorgan Chase & Co. (JPM)
Visa Com Cl A (V)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for Diam

Top funds holding Kiniksa Pharmaceuticals Intl P Ord Shs Cl A

Rubric Capital Management
Vanguard Group
Baker Bros. Advisors
Tang Capital Management
Fairmount Funds Management
Acadian Asset Management
D. E. Shaw & Co
Arrowstreet Capital, Limited Partnership
Morgan Stanley
Millennium Management
Pictet Asset Management Holding SA
FMR
Connor, Clark & Lunn Investment Management
Qube Research & Technologies
Parkman Healthcare Partners

View all funds holding Kiniksa Pharmaceuticals Intl P Ord Shs Cl A